Metraipolis › archive › dc_6b73fed44249

The Path Towards Effective Long-Lasting Tissue-Targeted Prime/Pull/Keep Herpes Simplex Therapeutic Vaccines — Europe PMC PMID:41012114

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41012114
DOI
10.3390/vaccines13090908
License (as archived)
solo-consultazione
Archived
2026-11-10T08:10:44.211Z
SHA-256 of the archived text
dd58f1dad8021a9b45be4c50dbec9d08db0e9711b798dd8215e414f8f1189702
Stable URL of this page
https://metraipolis.com/documento/dc_6b73fed44249

How to cite

The Path Towards Effective Long-Lasting Tissue-Targeted Prime/Pull/Keep Herpes Simplex Therapeutic Vaccines — Europe PMC PMID:41012114 — Europe PMC (en), https://europepmc.org/article/MED/41012114 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6b73fed44249 (Metraipolis archive dc_6b73fed44249, sha256 dd58f1dad8021a9b45be4c50dbec9d08db0e9711b798dd8215e414f8f1189702)
BibTeX
@misc{dc6b73fed44249,
  title = {The Path Towards Effective Long-Lasting Tissue-Targeted Prime/Pull/Keep Herpes Simplex Therapeutic Vaccines — Europe PMC PMID:41012114},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41012114},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6b73fed44249; sha256 dd58f1dad8021a9b45be4c50dbec9d08db0e9711b798dd8215e414f8f1189702},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41012114. Agents can read the archived copy with the MCP tool read_document.